A serial study of anticardiolipin antibody and antimitochondrial antibody type M5 in a patient with polyarthritis and polymyositis.
A 22-year-old female presented with polyarthritis and subsequent polymyositis. Initially, she had moderately high levels of anticardiolipin (aCl) and antimitochondrial antibody (AMA) type M5. Following corticosteroid therapy, the anticardiolipin antibody rapidly fell to background levels but reappeared with the onset of two significant clinical events.
Keane
A
A
Department of Rheumatology, Mater Misericordiae Hospital, Dublin, Eire.
Woods
R
R
Foley-Nolan
D
D
Roden
D
D
Coughlan
R
R
Barry
C
C
D000328:Adult; D000906:Antibodies / Q000032:analysis* / Q000145:classification; D001168:Arthritis / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D002308:Cardiolipins / Q000276:immunology*; D005260:Female; D006801:Humans; D008928:Mitochondria / Q000276:immunology*; D009220:Myositis / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D009288:Naproxen / Q000627:therapeutic use; D011239:Prednisolone / Q000627:therapeutic use
D000906:Antibodies; D002308:Cardiolipins; D009288:Naproxen; D011239:Prednisolone